Definitive Contract 75F40125C00066
Award Date 8/28/25
Potential Completion Date 6/15/28
Potential Value $4.2M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Labor Hours
Place of Performance
Beltsville, MD 20704, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...
- This is a direct 8(a) award of a 4-year, labor-hour type contract to Aneon Brillient, LLC to provide medical and scientific writing and editing services for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER). The contract has a ceiling value of $2,133,514.80. Aneon Brillient is a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture located in Reston, Virginia. The company specializes in providing professional services to...
- The U.S. Food and Drug Administration (FDA) has awarded a single-award, labor-hour (LH) contract to Aneon Brillient, LLC, an SBA certified 8(a) joint venture small disadvantaged business, to provide Freedom of Information Act (FOIA) support services for the FDA's Center for Biologics Evaluation and Research (CBER). This $1,479,584.76 ceiling value contract is a direct 8(a) sole source award with a period of performance through August 27, 2025. Aneon Brillient, a minority-owned limited...
- This is a direct 8(a) sole source, labor-hour type contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an 8(a) joint venture. The contract is for professional services to support the FDA's Oncology Center of Excellence, with an ultimate completion date of August 11, 2026 and a ceiling value of $2,220,109.12. Aneon Brillient, LLC specializes in providing a variety of professional services to the FDA,...
- This is a $144,964.92 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for additive manufacturing of medical products core facility support, on a labor-hour basis. Aneon Brillient is an SBA-certified 8(a) joint venture that specializes in providing professional services to the FDA, including across the Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation...
- This is a direct 8(a) sole source award of a 3-year, labor-hour (LH) type contract for program support services to the U.S. Food and Drug Administration (FDA), Office of Policy, Legislation and International Affairs (OPLIA). The contract has a ceiling value of $1,619,126.45 and was awarded to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. Aneon Brillient specializes in providing professional services to the FDA, with experience...
- <p>The Food and Drug Administration (FDA) awarded a 1-year, firm fixed price type contract to Aneon Brillient, LLC, an SBA certified 8(a) joint venture, to provide program support staff for the FDA's Office of Global Policy and Strategy. This is a direct 8(a) sole source award with a ceiling value of $152,077.08. The contract will be performed in Calverton, Maryland and has a completion date of June 12, 2025.</p>
- This is a federal contract award from the Food and Drug Administration (FDA), a civilian agency, to Brillient Corporation, a minority-owned small business. The contract, valued at $139,863.45, is for administrative support services and is a call order under the FDA's Professional and Technical Services Blanket Purchase Agreement (BPA). The contract has an ultimate completion date of August 26, 2024. Brillient Corporation is an experienced federal contractor, having been awarded numerous...
- This is a labor hour award from the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA) to Brillient Corporation, a Minority Owned Business, for science database administration support services. The contract was awarded under the Professional and Technical Services Blanket Purchase Agreement on the Professional Services Schedule (PSS) of the General Services Administration (GSA). The contract has a potential value of $194,765.86 and runs through May...
- The Department of Health and Human Services Food and Drug Administration awarded a $6.1 million Blanket Purchase Agreement Call contract to Brillient Corporation, doing business as Brillient Corp, to provide professional and technical services support to OSE staff on various projects through June 2022. Under the contract, Brillient will supply contracted personnel through a Multiple Award Schedule held with the General Services Administration to fulfill statutory obligations, user fee...